|
18 Nov 2009
Central and Eastern Europe's Medical Tourism
Potential Since the European Union (EU) was expanded in 2004 - there
are trends that point to the increasing importance of medical tourism in countries from Central and Eastern Europe.
These include countries such as Poland, the Czech Republic, Hungary, Croatia, Bulgaria, Romania, Armenia, Ukraine, Republic
of Georgia, Turkmenistan, and Russia. Although all regions in the world recorded a decrease in overall tourism traffic
through the first half of 2009- Europe (-8%) is still enduring the impact of recession in a majority of its source markets
and showing some encouraging improvement in the second half of the year. With almost all European countries faced with
rapidly aging populations, the continued pressures on their nationalized healthcare systems, and the large number of residents
that are savvy international travelers (compared to the U.S. which only has 25% of its population with a Passport)- it seems
only natural that this industry has great potential. Many countries in the EU (particularly in the Central and Eastern
region) are expected to benefit from increased liberalization of health-related labor markets and mutual recognition of healthcare
certifications and qualifications. There are possibly still some barriers caused by slight linguistic and cultural differences.
In addition, it is suggested that many of the former communist-bloc countries are still somewhat new to advertising, marketing
and private healthcare. However, there is no doubt that medical tourism is a strategic growth industry for this region
and could even better the 35% growth mark suggested for the medical tourism industry by Deloitte in 2009.
There
are some signs the EU is encouraging medical tourism by creating opportunities for international private medical insurance
(PMI) providers and standardizing electronic medical/health records (EMR or EHR). According to Frost & Sullivan,
the European healthcare industry has seen many early initiatives to develop the infrastructure to make patient health records
available to the various stakeholders and decision makers (and to make intra-regional medical tourism more feasible). Although,
individual physician practices/clinics and hospitals have been acquiring electronic medical records (EMR) systems at a slow
pace, the industry has witnessed the implementation of projects involving the use of telemedicine technologies, regional healthcare
networks and solutions like the electronic health-card systems which will continue to serve as a catalyst to this market.
Currently, it reported that promotional campaigns advertising medical tourism packages and medical vacation options
are being aired on television in EU countries. Right now, there are many opportunities for Northern and Western to get
lower-cost medical and dental care as well as assess procedures that are either not covered or require long wait times in
their nationalized systems. Some brief examples of the growing importance of Central and Eastern European medical tourism
practices are found below: - Many Germans are travelling to Szczecin, Poland (which is less
than 100 miles from Berlin), for low-cost, high-quality dental work;
- Sopron, Hungary (which
is less than an hour's drive from Vienna, Austria) is reported to have more than 200 dentists and 200 optometrists, 10
times as many as would be expected in a town their size, and therefore is pursuing medical tourists from other European countries;
- Croatia is establishing itself as a location for low-cost treatments (suggested that they may be only a third of
that charged in Western Europe) and high standard of care (particularly in dentistry, surgery and aesthetic surgery);
- Armenia is offering cosmetic or dental procedures such as laser hair removal and corrective laser eye surgery (as
well as more complex procedures including open-heart surgery) and reduced rates from other EU countries;
- An American company (Stem Cells for Hope), which researches and develops the treatment of patients with stem cell
transplantation therapy, made news by opening operations in both the Ukraine and the Republic of Georgia; and
- Patients from throughout Europe (especially from Italy, Germany, and Scandinavian countries) visit Ukraine for fertility
treatments (including surrogate maternity, extracorporeal fertilization, and in vitro fertilization or IVF) because facilities
in these countries meet all necessary legal regulation to offer these treatment and cost less than elsewhere in the EU.
This is leading to the rapid investment of state-of-the-art medical centers and even growth in the wellness market
in Central and Eastern European countries. For example, in Turkmenistan there is a $5 billion USD health/medical tourism
project (funded by foreign investors) under way to create a center for health tourism including sanatoria, health centers,
spas, hotels and other tourism facilities. As reported at the Global Spa Summit, in terms of revenues, number of spas,
and employment, Europe is the largest regional spa market in the world (with an estimated 22,607 spas earning $18.4 billion
in revenues and employing 441,727 people). Offshoots of traditional spa with include Medspas/Medispas or health spas
(which combine both medical and wellness or spa procedures- includes bath house and sauna facilities) are becoming especially
prevalent in Northern and Eastern European countries (particularly the former Soviet Bloc countries). These are a fast-growing
trend within medical tourism and Europe has a unique advantage because it has a large number of these health resorts that
emphasize wellness, traditional healing therapies, and medically-based services. For example, in Russia and Eastern Europe,
there are possibly thousands of sanatoriums (dating from the Soviet era) which now offer wellness-based healing/medical services.
Particularly when these facilities are modernized and branded as high-end health resorts that are meeting a very unique
niche need for consumers. Overall, it is reported that in 2007, health resorts and destination spas made up an estimated
27% of European spa industry revenues (and Germany, Russia, and Austria made up 3 of the top 7 EU countries in terms of numbers
of spas). Summary In their HealthCast 2020:
Creating a Sustainable Future report, Pricewaterhouse Coopers suggests that Europe's healthcare system and policy makers
are learning to embrace competition. Through the growth of medical tourism in the Central and Eastern regions of Europe,
it is clear that competition is truly growing in this industry on the continent. An interesting point to be made is
that (according to the World Bank) in the Central, Eastern, and Baltic European countries, many of which have had to restructure
their previously state-owned hospitals into public enterprises, there is reportedly more direct and hierarchical control over
the administration of theses facilities. This may actually lead to more entrepreneurial and aggressive business models
than will be found in the rest of Europe. As an area, the EU encompasses such a wide range of countries with vastly
different levels of income and stages of economic development and maturity. Reportedly, PPP GDP per capita in Europe
ranges from under $2,000 USD in some of the former Soviet countries to over $60,000 USD in the most wealthy Western and Northern
European countries (as of 2007). Because of this heterogeneity, there are significant price differentials in the services
offered by healthcare practitioners and facilities. As these continue to be exploited and the quality (and reputation)
of healthcare continues to rise in this region- it seems to be many medical tourism opportunities to be found in Central and
Eastern Europe.
About the Author David
G. Vequist IV, Ph.D. is the founder and Director of the Center for Medical Tourism Research and a Professor at the University
of Incarnate Word in San Antonio, Texas, USA. He is also a consultant, author and speaker on topics such as healthcare
trends and technologies. He can be reached at vequist@uiwtx.edu. References
Electronic Medical
Records - European Perspective, 4 Apr 2004, Siddharth Saha Healthcare, Retrieved from: http://www.frost.com/prod/servlet/market-insight-top.pag?docid=17055864 Europe: Medical tourism development in Central and Eastern Europe, 13 November 2009, Retrieved from:
http://www.imtj.com/news/?entryid82=167820&source=email&campaign=imtj_news_091113 Global Tourism Staging a Comeback, Says UNWTO, Monday, 12/10/2009, Retrieved from: http://www.caribbeannewsdigital.com/en/news/16223/global_tourism_staging_a_comeback_says_unwto HealthCast 2020: Creating a Sustainable Future, PricewaterhouseCoopers, 2005 Hospital
Governance in Latin America: Results from a Four Nation Survey, Richard J. Bogue, Claude H. Hall, Jr., and Gerard M. La Forgia,
World Bank, 2007 International Mobility of Health Professionals: Brain Drain or Brain Exchange?,
Stephen Bach, August 2006, United Nations Medical Tourism: Updates and Implications, Deloitte,
2009 Medical Tourists Head to Croatia, Armenia, or Even Turkmenistan, 27 July 2009, Retrieved
from: http://www.tourism-review.com/article/1744-medical-tourists-head-to-croatia-armenia-or-even-turkmenistan Sharon Reier, "Medical Tourism: Border Hopping for Cheaper and Faster Care Gains Converts,"
International Herald Tribune, April 24, 2004 The Global Spa Economy 2007- Proceedings from the
2008 Global Spa Summit The Center for Medical Tourism Research: The First Center in the World Devoted to the Medical Tourism Industry Another
first is occurring in the Medical Tourism industry. The newly launched Center for Medical Tourism Research (http://www.medicaltourismresearch.org/) is located in the H-E-B School of Business & Administration at the University of the Incarnate Word (UIW)
in San Antonio, Texas, USA. This center is the first academic research center in the world devoted to medical tourism
research. The center's founder and Director is David George Vequist IV, Ph.D. who is regarded as one of the leading
academic speakers and authors on medical tourism. The Vision of the Center To serve as the premier academic center for Medical Tourism/Travel research in the world. The center will provide
high-quality research and thought-leadership in the economic, social justice, and societal impacts of the Medical Tourism/Travel
industry. The center will also uphold the Mission of the University of the Incarnate Word: Faith; Service; Innovation;
Truth; and Education. What Does the Center Do? The
center is aggressively pursuing primary data and accumulating secondary data to support the development of thought leadership,
best practices, lessons learned, and policy formulation in the new industry of Medical Tourism. As part of its purpose,
the center will supply the myriad of stakeholders with leading edge research and the truth about the impacts of this trend
on the countries, companies and people involved in this industry through both the Center websites and its various articles
and papers.
16 Sept 2010
Global Engage have announced their 2010 events
We have just announced our 2010 programme.
More detail on each will be published soon, but the calendar can be viewed by clicking here.
3 Sept 2009
Speaker Update
We are please
to annouce the addition of a new and very important speaker to the China Clinical Trials Outsourcing Congress. Dr. Jason (Gang) Jin, CEO
of the ShanghaiBio Corporation.
ShanghaiBio
Corporation (SBC for Global R&D Services), is a leading biotech in China with business operations in the U.S.
It performs a full spectrum of GLP/GMP-compliant R&D services for global pharma/biotech companies. Dr. Jin is the Co-Founder and Executive Vice President of Global Business
(CRO) of Shanghai Biochip Co. Ltd (SBC) & CEO of ShanghaiBio Corporation (SBC for Global R&D Services in USA). Dr.
Jin is also an adjunct professor at the Shanghai Institute of Biological Sciences (SIBS) and the Chinese Academy of Sciences
(CAS). Dr. Jin has extensive scientific and business development experience in drug discovery and development. He has
successfully developed and managed a number of R&D collaborative projects in biology discovery, preclinical research,
and clinical trials with top global pharmaceutical and biotech companies. Dr. Jin has held the former positions of Director
of Genomics Lab at Purdue Pharma (USA), Director of Functional Genomics at Salk Institute (USA), Founder Director of National
Engineering Center for Biochip at Shanghai (China), and radiologist at Shanghai Zhongshan Hospital (China). He received Ph.D.
and Postdoctoral Fellow in biology from University of California, San Diego (USA), and medical degree from School of Medicine,
Fudan University (Shanghai Medical University, China).
He is a very important figure and will bring a wealth of
experience and knowledge to the congress, for the benefit of our delegates.
30 June 2009
First
CROs selected for China’s express customs scheme
Three Chinese CROs Sundia MediTech, Huiyuan Biotechnology
and Frontage Laboratories are the first companies granted express customs clearance privileges under new government pro outsourcing
rules. The contract research sector is growing 13 per cent a year and will be worth $12.3bn in 2011 and this rapid growth
has increased the number of contract research organisations (CROs) importing clinical candidates creating a customs clearance
bottleneck, which is bad news for a sector where timelines are critical.
In April the Chinese government acknowledged
the detrimental impact such delays can have on Chinese CROs and promised an express clearance programme as part of a wider
policy to encourage further growth of the outsourcing sector. Under the initial scheme the three firms can use a number of
measures, including pre-declaration and 24-hour review protocols, to expedite the importation process. If successful the scheme
will be rolled out to other CROs based on a review of the individual company’s internal management system, track record
and reputation.
While the Chinese CRO sector is still a relatively small part of the global clinical trials market
it has grown considerably as a result of the Asian pharmaceutical outsourcing boom. Any strategy that helps CROs cut
development times is likely to be welcomed by the drug industry. A recent survey of pharma firms by Cutting Edge Information
ranked the ability to hit deadlines as the critical factor in selecting a development partner.
10 June 2009
Global Engage announces the launch of the China Clinical Trials Outsourcing Congress
This will bring together Chinese CROs with relevant companies
from the West. Together we shall plot the necessary steps to plan your future Clinical Trials model. The congress
will look at the commercial advantages of Chinese trials (from cost cutting to new market opportunities) and the considerations
required before making the jump.
|